GLP-3 "RT" — 30 mg

GLP-3(research designation LY3437943) — synthetic single-molecule agonist of the GIP, GLP-1, and glucagon receptors, studied in preclinical and clinical-stage research for incretin and energy-metabolism pathways. Research Use Only; not for human or veterinary consumption. Lyophilized, ≥98% purity, 30 mg per vial.